Methadone Clinics in Maine

Methadone clinics in Maine provide opiate dependent individuals with medically assisted treatment that guides their recovery to a state of sobriety and health.

Methadone Clinics in cities of Maine

Medication Treatment for Opioid Use Disorder Across Maine

Maine treats opioid use disorder (OUD) with the same three FDA-approved medications used nationwide, but access here is shaped by geography.

Cumberland County and the greater Portland area hold the densest concentration of clinics and office-based prescribers. Because much of the state is rural, the nearest opioid treatment program may sit in a neighboring county and telehealth carries a real share of care.

Methadone, buprenorphine (including Suboxone) and naltrexone (including Vivitrol) are all available in the state, through both clinic- and office-based providers. The listings on this page point you toward local options, and the helpline can talk you through where to start.

The Three Medications and the Two Places You Can Get Them

There are three medications approved for opioid use disorder and understanding how they are prescribed makes the listings easier to read.

Methadone for OUD is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy. So, it involves a certified clinic and, early on, more frequent visits.

Buprenorphine, which includes Suboxone and other buprenorphine-naloxone products, including the extended-release injection Sublocade, can be prescribed in a doctor’s office and filled at a pharmacy, or provided inside a clinic.

Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider, but it starts only after a person has been off opioids for a set stretch of time.

These medications are available through two settings. An opioid treatment program is the clinic model and is the only setting that can dispense methadone for OUD.

An office-based opioid treatment (OBOT) means a physician, nurse practitioner or physician assistant can prescribe buprenorphine or naltrexone in a regular medical office, with prescriptions filled at your pharmacy.

A side-by-side look at how methadone and Suboxone differ can help you weigh the daily-dosing clinic model against office-based care. You and your clinician can determine which would be a good fit for your situation. Both settings exist in Maine, and which one fits will depend on where you live, the medication you want and your schedule.

State Rules, MaineCare coverage and Paying for Care

MaineCare, Maine’s Medicaid program, covers all three medications for opioid use disorder, and the Office of Behavioral Health provides funding for people who are uninsured or underinsured. Much of Maine’s care is organized through Opioid Health Homes, a MaineCare team-based model that pairs medication with counseling and care coordination.

A 2022 MaineCare rule change formally replaced the older “medication-assisted treatment” language with “medications for opioid use disorder” to reflect that the medication is treatment in its own right.

Federal rules set the floor that Maine builds on. Since 2023, any clinician with a standard DEA registration can prescribe buprenorphine for OUD, which widened where people can get it. As of 2026, buprenorphine can be initiated via telehealth, including by phone in many cases and without a prior in-person visit.

Keep in mind that these telehealth flexibilities run through the end of 2026 and are still being finalized, so be sure to confirm your current options with a provider.

Methadone for OUD remains dispensed through an OTP. Federal rules updated in 2024 expanded take-home methadone (up to a 28-day supply for patients who are stable in treatment), allowed treatment to start by telehealth and removed older barriers to admission. Staying consistent with a methadone dose is part of what makes take-home privileges possible over time.

Where Maine’s Overdose Numbers Stand Now

Maine has seen a sustained decline in overdose deaths. According to preliminary data from the University of Maine reported by Governor Mills’ office, 390 people died from a drug overdose in 2025, a 20 percent drop from 490 in 2024 and the lowest count since 2019.

Nonfatal overdoses fell over the same period, from 8,040 in 2024 to 7,313 in 2025. Nonpharmaceutical fentanyl remains the drug most often involved, named in 72 percent of confirmed 2024 overdose deaths and is frequently seen alongside cocaine, methamphetamine or the sedative xylazine. State officials credit the decline to a mix of naloxone distribution, outreach, treatment expansion, and a less potent street supply.

These numbers describe real loss in Maine communities, and they also point to why fast access to effective treatment matters. The listings above and the helpline are a starting point. You can read more about how opioid addiction develops and why medication helps if you are new to this.

Starting Treatment, and Finding it in Your Part of the State

Getting started usually begins with an assessment, where a provider reviews your history and, if appropriate, plans a first dose. One caution matters most when fentanyl is involved: starting buprenorphine too soon after using can trigger sudden, severe withdrawal, called precipitated withdrawal, so a clinician must time that first dose carefully.

Some Maine emergency departments now offer rapid buprenorphine induction, reaching therapeutic levels in hours rather than days. Maine also runs the OPTIONS initiative (Overdose Prevention Through Intensive Outreach, Naloxone and Safety), which places behavioral health liaisons alongside EMS and law enforcement in every county to connect people to treatment after an overdose or outreach contact.

If you live where the nearest clinic is far, ask a provider about telehealth for buprenorphine and, once you are stable, take-home dosing.

The broader picture of opioid treatment options can help you decide what to look for, including facility-based intensive level of care. Inpatient treatment is a different track from the outpatient medication care most listings here represent. Use the listings by city to find providers near you.

Pregnancy, Parents and People Leaving Incarceration

Two situations in Maine carry specific support. For pregnancy, medication for opioid use disorder is the recommended standard of care. For this reason, Maine runs MaineMOM (the Maine Maternal Opioid Model), a MaineCare program at sites across the state that integrates prenatal care, substance use treatment, a nurse care manager and a recovery coach for pregnant and postpartum people.

You can find service locations at MaineMOM.org. Every substance-exposed infant in Maine is meant to have a Plan of Safe Care, a supportive plan rather than a punitive one, and continuing treatment during pregnancy is what the evidence supports. Check out More on methadone and pregnancy, which covers what to expect.

For people leaving jail or prison, the Maine Department of Corrections operates a medication program with naloxone provided at release and linkage to community treatment. This high-risk transition period is where staying on medication saves lives. Families supporting someone in this situation can learn more at guidance for families.

Naloxone and Overdose Safety in Maine

Naloxone, the medication that reverses an opioid overdose, is widely available in Maine. Pharmacists here can prescribe and dispense it to anyone at risk or in a position to help, of any age, without a separate prescription.

Additionally, the statewide Maine Naloxone Distribution Initiative supplies free kits through community organizations. Maine Access Points will mail naloxone anywhere in the state and provide overdose-response training.

Maine’s Good Samaritan Law protects both the person who calls 911 for an overdose and the person overdosing from arrest for drug possession, with no requirement to be the first to call or to give a name.

Keep in mind that a return to use is a common and manageable part of recovery from a chronic condition, not a failure. So, having naloxone on hand is a practical safeguard for anyone at risk. See how to recognize and respond to an opioid overdose for the basics.

Common Questions About MOUD in Maine

Does MaineCare pay for methadone or Suboxone?

Yes. MaineCare covers all three medications for opioid use disorder, and the Office of Behavioral Health funds care for people who are uninsured or underinsured. Coverage details and any prior-authorization steps can be confirmed with MaineCare Member Services or the provider before your first visit.

Can I start Suboxone by telehealth in Maine?

In many cases, yes. As of 2026, buprenorphine can be initiated via telehealth, including by phone in defined circumstances and in some cases, without a prior in-person visit. These federal flexibilities continue through the end of 2026 and are still being finalized.

Do I have to go to a clinic every day for methadone?

Early in treatment, dosing is more frequent. Federal rules updated in 2024 allow take-home methadone up to a 28-day supply for stable patients, with eligibility decided by the program. Long-term methadone treatment often becomes less day-to-day over time.

What’s the difference between methadone and Suboxone?

Both are effective medications for OUD. Methadone for OUD is dispensed only through a licensed clinic, while buprenorphine (Suboxone) can be prescribed in an office and filled at a pharmacy. The right fit is something to decide with a clinician. You can read more answers to common treatment questions as you compare.

Is it hard to get treatment in rural Maine?

It can mean more travel, since clinics cluster in more populated areas. Telehealth for buprenorphine and, once you are stable, take-home dosing are designed to close that gap, and the OPTIONS initiative operates in every county to help connect people to care.

Last Reviewed and Disclosures

Last reviewed July 2026.

Sources:

Office of Governor Janet T. Mills, “Governor Mills Announces 20 Percent Decline in Fatal Drug Overdoses in 2025,” 2026.
Maine Drug Data Hub, Monthly Overdose Report and Focus Area: Treatment, 2025.
Maine Department of Health and Human Services, Office of Behavioral Health, MOUD resources and MaineMOM (MaineCare Benefits Manual, Chapter II, Section 89), 2023 to 2025.
MaineCare, Opioid Health Home Services rule (Chapter II, Section 93), 2022.
SAMHSA and DEA, buprenorphine telemedicine final rule and Fourth Temporary Extension of telemedicine flexibilities, 2025 to 2026.
SAMHSA and FDA, medications for opioid use disorder overview and 42 CFR Part 8 (2024 revision).
Maine Legislature, Good Samaritan Law (LD 329, 2019) and pharmacist naloxone prescribing authority (Title 32).

MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. MethadoneCenters.com does not endorse any treatment facility or guarantee the quality of care provided or the results to be achieved by any treatment facility. The information provided is not a substitute for professional treatment advice.

Calls to any general helpline may be answered or returned by a paid advertiser. By calling the helpline, you agree to the terms of use. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.

Call For Help With Addiction

Talk To Someone Now